DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
GUSUIBU
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GUSUIBU
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986156
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-986156
×
Maximum Phase:
1
First Approval:
None
UNII:
V0XQ564M2L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04605412
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Fibronectin receptor alpha inhibitor
PF-04605412
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YTTRIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
YTTRIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
58784XQC3Y
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
88.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRIS(8-HYDROXYQUINOLINATO)GALLIUM
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRIS(8-HYDROXYQUINOLINATO)GALLIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
R3G3HB38O4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3031207
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY-3031207
×
Maximum Phase:
1
First Approval:
None
UNII:
NQ7VQ61PBC
Molecule Type:
Small molecule
Molecular Formula:
C16H19ClN4O2
Molecular Weight:
334.81
AlogP:
2.98
PSA:
86.88
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ENADENOTUCIREV
1
Unknown
Investigational
Unknown
Unknown
Ovarian Neoplasms; Rectal Neoplasms
Unknown
ENADENOTUCIREV
×
Maximum Phase:
1
First Approval:
None
UNII:
KX7ZYR6OQW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ALVIRCEPT SUDOTOX
1
Protein
Investigational
Unknown
Unknown
HIV Infections
Unknown
ALVIRCEPT SUDOTOX
×
Maximum Phase:
1
First Approval:
None
UNII:
Q67R7N520V
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PI-0824
1
Unknown
Investigational
Unknown
Unknown
Pemphigus
Unknown
PI-0824
×
Maximum Phase:
1
First Approval:
None
UNII:
UG5KU6AQ0Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-3281
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-3281
×
Maximum Phase:
1
First Approval:
None
UNII:
3593C180JO
Molecule Type:
Small molecule
Molecular Formula:
C29H37N3O3
Molecular Weight:
475.63
AlogP:
5.31
PSA:
57.94
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PF-04603629
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
PF-04603629
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-3043
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-3043
×
Maximum Phase:
1
First Approval:
None
UNII:
372AB76LQL
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO5
Molecular Weight:
351.44
AlogP:
2.83
PSA:
65.07
HBD:
0.0
HBA:
#RotB:
11.0
Source:
AUTOLOGOUS HUMAN UMBILICAL CORD BLOOD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AUTOLOGOUS HUMAN UMBILICAL CORD BLOOD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DM-1157
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
DM-1157
×
Maximum Phase:
1
First Approval:
None
UNII:
6X58GJ0RMS
Molecule Type:
Small molecule
Molecular Formula:
C28H31ClN6
Molecular Weight:
487.05
AlogP:
5.32
PSA:
65.97
HBD:
2.0
HBA:
#RotB:
9.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
L-FUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-FUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
28RYY2IV3F
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SCIO-323
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SCIO-323
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H30FN3O4
Molecular Weight:
479.55
AlogP:
3.69
PSA:
71.85
HBD:
0.0
HBA:
#RotB:
6.0
Source:
AGN-201904
1
Small molecule
Investigational
Unknown
Unknown
Peptic Ulcer
Unknown
AGN-201904
×
Maximum Phase:
1
First Approval:
None
UNII:
G0835O03ZM
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O8S2
Molecular Weight:
559.62
AlogP:
3.07
PSA:
146.91
HBD:
1.0
HBA:
#RotB:
10.0
Source:
METHYLSELENOCYSTEINE
1
Small molecule
Investigational
Unknown
Unknown
Adenoma; Lymphoma; Prostatic Neoplasms
Unknown
METHYLSELENOCYSTEINE
×
Maximum Phase:
1
First Approval:
None
UNII:
TWK220499Z
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2Se
Molecular Weight:
182.08
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-986120
1
Unknown
Investigational
Unknown
Unknown
Thrombosis
Unknown
BMS-986120
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LHC-165
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
LHC-165
×
Maximum Phase:
1
First Approval:
None
UNII:
RD02U4QLM1
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KPT-9274
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin
Unknown
KPT-9274
×
Maximum Phase:
1
First Approval:
None
UNII:
9T56TV18X7
Molecule Type:
Small molecule
Molecular Formula:
C35H29F3N4O3
Molecular Weight:
610.64
AlogP:
7.08
PSA:
101.46
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PRT-2607
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase SYK inhibitor
PRT-2607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVID-200
1
Unknown
Investigational
Unknown
Unknown
Neoplasms; Scleroderma, Diffuse
Unknown
AVID-200
×
Maximum Phase:
1
First Approval:
None
UNII:
6EX05GL2VK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-3C5
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Vascular endothelial growth factor receptor 3 inhibitor
IMC-3C5
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DSTP3086S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
DSTP3086S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC-065
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
Unknown
CYC-065
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DS-8273A
1
Unknown
Investigational
Unknown
Unknown
Colorectal Neoplasms; Lymphoma; Melanoma
Unknown
DS-8273A
×
Maximum Phase:
1
First Approval:
None
UNII:
G674PEN33T
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRV-120027
1
Protein
Investigational
Unknown
Unknown
Heart Failure; Severe Acute Respiratory Syndrome
Unknown
TRV-120027
×
Maximum Phase:
1
First Approval:
None
UNII:
J1J4P3PQZD
Molecule Type:
Protein
Molecular Formula:
C43H67N13O10
Molecular Weight:
926.09
AlogP:
-1.91
PSA:
355.05
HBD:
13.0
HBA:
#RotB:
26.0
Source:
MMI-0100
1
Protein
Investigational
Unknown
Unknown
Inflammation
Unknown
MMI-0100
×
Maximum Phase:
1
First Approval:
None
UNII:
6VP6PBL1ZH
Molecule Type:
Protein
Molecular Formula:
C98H171N37O26
Molecular Weight:
2283.68
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NONA-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
1
2
…
113
114
115
116
117
118
119
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA